MERUS LABS INTERNATIONAL INC
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 43.3B | ||||||
| 22.22B | ||||||
| 15.43B | ||||||
| 14.48B | ||||||
| 12.72B |
